Aurora Spine Corp. engages in the development and distribution of spinal implant products. The company is headquartered in Toronto, Ontario. The company went IPO on 2013-09-10. The Company’s products generally fall into three product lines: interspinous process (ISP) lumbar fusion devices, Stand-alone (SA) Cervical and Lumbar fusion cages, and SI joint fusion devices. Its ISP lumbar fusion devices include the ZIP, the ZIP ULTR, the ZIP LP and the ZIP-51. The company also offers a line of interbody products: Discovery for cervical procedures; SOLO, an ALIF 3D-printed stand-alone lumbar fusion device; SiLO, a posterior allograft implant; and SiLO TFX, a titanium implant device, both for sacroiliac (SI) joint fusion, and Dexa-C a 3D printed cervical fusion device which is paired with the Apollo cervical plate. In addition, the Company markets certain third-party-developed products used during spine surgeries (i.e. surgical screws and bone growth biologic materials).
How did ASAPF's recent EPS compare to expectations?
The most recent EPS for Aurora Spine Corp is $, expectations of $.
How did Aurora Spine Corp ASAPF's revenue perform in the last quarter?
Aurora Spine Corp revenue for the last quarter is $
What is the revenue estimate for Aurora Spine Corp?
According to of Wall street analyst, the revenue estimate of Aurora Spine Corp range from $ to $
What's the earning quality score for Aurora Spine Corp?
Aurora Spine Corp has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Aurora Spine Corp report earnings?
Aurora Spine Corp next earnings report is expected in 2026-02-17
What are Aurora Spine Corp's expected earnings?
Aurora Spine Corp expected earnings is $, according to wall-street analysts.
Did Aurora Spine Corp beat earnings expectations?
Aurora Spine Corp recent earnings of $ expectations.